Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmiths Group Regulatory News (SMIN)

Share Price Information for Smiths Group (SMIN)

Share Price is delayed by 15 minutes
Get Live Data
2,510.00    0.00 (0.00%)
Bid:
2,246.00
Ask:
2,800.00
Spread: 554.00 (24.666%)
Market Cap: £7.53b
SMIN Live PriceLast checked at - London Stock Exchange

Intraday Smiths Group Share Chart

SHARE BUYBACK PROGRAMME

29 Mar 2023 07:00

RNS Number : 5332U
Smiths Group PLC
29 March 2023
 

29 March 2023

 

SMITHS GROUP PLC

 

SHARE BUYBACK PROGRAMME

 

Smiths Group plc ("Smiths" or the "Company") announces that, in connection with the share buyback programme (the "Programme") of up to £742 million which it announced on 11 November 2021, Smiths has extended the fifth tranche of the Programme to purchase ordinary shares in the capital of the Company (the "Ordinary Shares") with a value of up to £83 million, subject to remaining within the Company's general authority to repurchase Ordinary Shares granted by its shareholders at its General Meeting on 17 November 2021 (the 2021 GM authority is for a maximum of 59,435,913 shares).

 

The Company has extended the agreement with Goldman Sachs International ("Goldman Sachs") under which Goldman Sachs will continue to manage the fifth tranche of the Programme which will conclude no later than 30 September 2023 or once the £742 million programme has completed (the "Engagement Period"). The purpose of the Programme is to reduce the share capital of Smiths. 

 

Goldman Sachs will carry out the instruction through the acquisition of Ordinary Shares in the Company for subsequent repurchase and cancellation by the Company. This arrangement is in accordance with the Company's general authority to repurchase Ordinary Shares, Chapter 12 of the Financial Conduct Authority's Listing Rules, Article 5(1) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and Commission Delegated Regulation (EU) 2016/1052 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018).

 

Goldman Sachs may undertake transactions in the Company's Ordinary Shares (which may include sales and hedging activities, in addition to purchases which may take place on any available trading venue or on an over the counter basis) during the Engagement Period in order to manage its market exposure under the Programme. Disclosure of such transactions will not be made by Goldman Sachs as a result of or as part of the Programme, but Goldman Sachs will continue to make any disclosures it is otherwise legally required to make.

 

Enquiries:

 

Jemma Spalton, Director of Communications & Investor Relations+44 (0)20 7004 1600

Jemma.splaton@smiths.com

Matthew Whyte, Company Secretary+44 (0)20 7004 1600Matthew.whyte@smiths.com

 

 

Legal Entity Identifier (LEI): 213800MJL6IPZS3ASA11

 

About Smiths Group

 

For over 170 years, Smiths Group has been pioneering progress by improving the world through smarter engineering. We serve millions of people every year, to help create a safer, more efficient and better-connected world, across four major global markets: Energy, General Industry, Security & Defence, and Aerospace. Listed on the London Stock Exchange, Smiths employs c. 14,600 colleagues in over 50 countries. For more information visit www.smiths.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSEAXDPAEXDEFA
Date   Source Headline
21st Feb 20227:00 amRNSTransaction in Own Shares
18th Feb 20227:00 amRNSTransaction in Own Shares
17th Feb 20227:00 amRNSTransaction in Own Shares
16th Feb 20227:00 amRNSTransaction in Own Shares
15th Feb 202211:00 amRNSNotice of Redemption Price
15th Feb 20227:00 amRNSTransaction in Own Shares
14th Feb 20227:00 amRNSTransaction in Own Shares
11th Feb 20227:30 amRNSShare Buyback Programme
11th Feb 20227:00 amRNSTransaction in Own Shares
9th Feb 20227:00 amRNSTransaction in Own Shares
8th Feb 20227:00 amRNSTransaction in Own Shares
7th Feb 20227:00 amRNSTransaction in Own Shares
4th Feb 20227:00 amRNSTransaction in Own Shares
3rd Feb 20227:00 amRNSTransaction in Own Shares
2nd Feb 20227:00 amRNSTransaction in Own Shares
1st Feb 20222:30 pmRNSDirector/PDMR Shareholding
1st Feb 20222:00 pmRNSDirector Responsibilities
1st Feb 20221:30 pmRNSTotal Voting Rights
1st Feb 20227:00 amRNSTransaction in Own Shares
31st Jan 202212:00 pmRNSHolding(s) in Company
31st Jan 20227:00 amRNSTransaction in Own Shares
28th Jan 20227:00 amRNSTransaction in Own Shares
27th Jan 20227:00 amRNSTransaction in Own Shares
26th Jan 20227:00 amRNSTransaction in Own Shares
25th Jan 20227:00 amRNSTransaction in Own Shares
24th Jan 20227:00 amRNSTransaction in Own Shares
21st Jan 20228:00 amRNSAdditional Listing
21st Jan 20227:00 amRNSTransaction in Own Shares
20th Jan 20227:00 amRNSTransaction in Own Shares
19th Jan 20227:00 amRNSTransaction in Own Shares
18th Jan 20227:00 amRNSTransaction in Own Shares
17th Jan 20227:00 amRNSTransaction in Own Shares
14th Jan 20227:00 amRNSTransaction in Own Shares
13th Jan 202210:10 amRNSNotice of Optional Redemption
13th Jan 20227:00 amRNSTransaction in Own Shares
12th Jan 20227:00 amRNSTransaction in Own Shares
11th Jan 20227:00 amRNSTransaction in Own Shares
10th Jan 20227:00 amRNSTransaction in Own Shares
7th Jan 20227:15 amRNSTransaction in Own Shares
7th Jan 20227:00 amRNSCompletion of Smiths Medical sale
6th Jan 20227:00 amRNSTransaction in Own Shares
5th Jan 20227:00 amRNSTransaction in Own Shares
4th Jan 20229:30 amRNSTotal Voting Rights
4th Jan 20227:00 amRNSTransaction in Own Shares
31st Dec 20217:00 amRNSTransaction in Own Shares
30th Dec 20217:00 amRNSTransaction in Own Shares
29th Dec 20217:00 amRNSTransaction in Own Shares
24th Dec 20217:00 amRNSTransaction in Own Shares
23rd Dec 20217:00 amRNSTransaction in Own Shares
22nd Dec 20217:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.